Mackenzie Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$684K Sell
348,989
-26,955
-7% -$63.2K ﹤0.01% 1163
2025
Q4
$1.01M Buy
+375,944
New +$1.23M ﹤0.01% 1054
2025
Q3
Sell
-184,047
Closed -$917K 1755
2025
Q2
$917K Buy
+184,047
New +$799K ﹤0.01% 1034
2023
Q4
Sell
-12,994
Closed -$68.3K 1535
2023
Q3
$68.3K Buy
+12,994
New +$86.6K ﹤0.01% 1386

Other funds holding GDRX

Mackenzie Financial's GDRX Position: Q1 2026 in Review

Mackenzie Financial reduced its GoodRx Holdings (GDRX) stake by 7.2% in Q1 2026, selling an estimated $63.2K and leaving 348,989 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

Mackenzie Financial first reported a position in GDRX in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.01M in Q4 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Mackenzie Financial held 348,989 shares of GoodRx Holdings worth $684K as of Q1 2026.
  • Mackenzie Financial sold 26,955 GoodRx Holdings shares in Q1 2026, an estimated $63.2K.
  • GoodRx Holdings made up ﹤0.01% of Mackenzie Financial's portfolio in Q1 2026, its #1163 holding.
  • Mackenzie Financial first reported a position in GoodRx Holdings in Q3 2023 and has held it in 4 quarters since.
  • Mackenzie Financial's GoodRx Holdings position peaked at $1.01M in Q4 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.